Skip to main content
Full access
Departments
Published Online: 1 April 2014

Post-ECT Hyperthermia and Rapid Mood Improvements: a Case Report

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: ECT is a safe and effective treatment for refractory major depression. Common side effects of ECT include headache, nausea, and mild memory impairment.1 ECT-associated hyperthermia has been rarely described.2,3
We report a case of repeated post-ECT hyperthermia associated with rapid, transient mood improvements in a patient with drug-resistant depression.

Case Report

Mr. A, aged 26, was admitted to a tertiary-care psychiatric hospital with a major depressive episode resistant to mirtazapine, fluvoxamine, bupropion, and sertraline. The patient's medical history was unremarkable. Neurologic and neuroimaging examination revealed no abnormalities and Mr. A was qualified to bitemporal ECT with a standard anesthetic protocol (atropine, thiopental, succinylcholine). Twelve ECT sessions were performed biweekly, between 9:00 a.m. and 11:00 a.m., with the aid of the Thymatron apparatus. Two hours after the first session, the patient complained of flu-like symptoms, including headache and fever. A rise in his body temperature exceeding 2°C (up to 38.8°C) was documented by tympanic membrane and oral temperature measurements. In the afternoon, a marked improvement in mood and drive was reported by the patient and confirmed by an on-duty psychiatrist. In the evening, Mr. A felt a reduction in flu-like symptoms and 24 hours after ECT his mood and body temperature returned to baseline levels.
A close correlation between post-ECT hyperthermia and transient improvements in depressive symptomatology was observed in sessions 1–7. When post-ECT hyperthermia was absent (session 2 and 4), no improvement or transient worsening in mental state was noted on the same day. A significant rise in body temperature (∆T>1°C) after sessions 1, 3, 5, and 7 was associated with rapid, transient mood improvements. Repeated physical and laboratory examinations showed no abnormalities. There was no relationship between the ECT-associated rise in body temperature and seizure duration or the course of anesthesia.
Post-ECT hyperthermia was not observed beyond session 7. ECT sessions 8–12 resulted in a stable improvement in depressive symptomatology.

Discussion

To the best of our knowledge, this is the first report on post-ECT hyperthermia associated with rapid, transient mood improvements in an adult patient with drug-resistant depression. One may hypothesize that post-ECT hyperthermia may be a correlate of successful stimulation of brain structures (e.g., the hypothalamus) involved in mood and thermal homeostasis.1,4,5 More detailed studies are needed to quantify post-ECT alterations in brain and body temperature and their relationship to short- and long-term clinical outcomes.

References

1.
Sienaert P: What we have learned about electroconvulsive therapy and its relevance for the practicing psychiatrist. Can J Psychiatry 2011; 56:5–12
2.
Vilkin MI: Fever following electroshock. Am J Psychiatry 1962; 118:946–947
3.
Bryson EO, Pasculli RM, Briggs MC, et al.: Febrile reaction with elevated CPK after a single electroconvulsive therapy (ECT) in an adolescent patient with severe bipolar disorder. J ECT 2012; 28:70–71
4.
Salerian AJ, Saleri NG, Salerian JA: Brain temperature may influence mood: a hypothesis. Med Hypotheses 2008; 70:497–500
5.
Bolwig TG: How does electroconvulsive therapy work? Theories on its mechanism.

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E21
PubMed: 24763777

History

Published online: 1 April 2014
Published in print: Spring 2014

Authors

Affiliations

Anna Z. Antosik-Wojcinska, M.D.
Institute of Psychiatry and Neurology, Warsaw, Poland
Dorota Bzinkowska, M.D.
Institute of Psychiatry and Neurology, Warsaw, Poland
Lukasz Swiecicki, M.D., Ph.D.
Institute of Psychiatry and Neurology, Warsaw, Poland
Przemyslaw Bienkowski, M.D., Ph.D.
Institute of Psychiatry and Neurology, Warsaw, Poland

Notes

Send correspondence to Dr. Bienkowski; e-mail: [email protected]

Competing Interests

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share